Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.78
Bid: 28.70
Ask: 28.74
Change: -0.40 (-1.37%)
Spread: 0.04 (0.139%)
Open: 29.00
High: 29.24
Low: 28.60
Prev. Close: 29.18
HMSO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cash Fractions for the Enhanced Scrip Dividend

6 Oct 2022 10:00

RNS Number : 9488B
Hammerson PLC
06 October 2022
 

 

THIS ANNOUNCEMENT (AND THE INFORMATION CONTAINED HEREIN) IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

 

FOR IMMEDIATE RELEASE

 

Hammerson plc (the 'Company')

 

Interim 2022 Dividend and Enhanced Scrip Dividend Alternative

 

Cash Fraction Applicable to the Enhanced Scrip Dividend Alternative

 

6 October 2022

Further to the announcements released on 28 July 2022, 27 September 2022, and 28 September 2022, Shareholders are further advised of the below.

 

Fractions applicable to the Enhanced Scrip Dividend Alternative:

Shareholders on the UK Register

No fraction of a New Share will be issued to Shareholders on the UK Register. Entitlements to New Shares of Shareholders on the UK Register who elect for the Enhanced Scrip Dividend Alternative will be rounded down to the nearest whole number of New Shares. Entitlements to fractions of New Shares will be paid to Shareholders who elect for the Enhanced Scrip Dividend Alternative in cash based on the value of the Enhanced Scrip Dividend Alternative. Such entitlements will be paid in the same way as the cash dividends are paid for the Interim 2022 Dividend.

Shareholders on the South Africa Register

No fraction of a New Share will be issued to Shareholders on the South Africa Register.

Shareholders on the South Africa Register cannot accumulate residual entitlements or receive a fraction of a New Share. Where you have made an election to participate in the Enhanced Scrip Dividend Alternative, which would otherwise give rise to an entitlement to a fraction of a New Share, the number of New Shares to be received will be rounded down to the nearest whole number of New Shares, and any residual entitlement which is less than the price of one New Share will be paid to you in cash in Rand.

The cash fractional payment for Shareholders on the South Africa Register is to be determined with reference to the volume weighted traded price on the Johannesburg Stock Exchange ("JSE") on Wednesday, 5 October 2022 (being the date on which the Shares began trading on the JSE ex the cash dividend or Enhanced Scrip Dividend Alternative) of 385.00 ZAR cents, discounted by 10% ("South Africa Fractional Reference Price"). Shareholders are accordingly advised that the South Africa Fractional Reference Price is 346.50 ZAR cents (385.00 ZAR cents discounted by 10%).

South African Taxation

The cash fractional payment is regarded as a dividend for South African tax purposes and will be subject to dividends tax to the extent that it is declared in respect of a share listed on the JSE. South African Dividends Tax at the rate of 20% will be withheld from such cash dividends paid to individuals, therefore the net fractional rate will be 277.20 ZAR cents. Shareholders are advised to seek their own tax advice from an independent tax adviser should they be in any doubt as to the tax treatment for them of any cash fractional payment.

A summary of how UK Shareholders and South Africa Shareholders are likely to be treated for tax purposes is set out in Section 2 of the Guide containing the terms and conditions of the Enhanced Scrip Dividend Alternative, which is available on the Company's website, https://www.hammerson.com/investors/dividend/scrip-dividend.

Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated Wednesday, 28 September 2022 in connection with (amongst other things) the proposed Interim 2022 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/dividend/scrip-dividend.

 

Registered Office

UK Registrars

SA Transfer Secretaries

Kings Place

90 York Way

London

N1 9GE

United Kingdom

Link Group

10th Floor

Central Square

29 Wellington Street

Leeds

LS1 4DL

 

Computershare Investor

Services Proprietary Limited

(Registration number

2004/003647/07)

1st Floor, Rosebank Towers

15 Biermann Avenue,

Rosebank, 2196

South Africa

(Private Bag, X9000, Saxonwold 2132 South Africa)

 

For further information contact:

 

Josh Warren

Director of Strategy and Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange and on Euronext Dublin.

 

This announcement is for information purposes only and is not intended to, and does not, constitute or form part of any offer to sell or issue, or the solicitation of an offer to purchase, subscribe for or otherwise acquire any securities of the Company, whether pursuant to this announcement or otherwise.

 

The New Shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the "US Securities Act"), or with any securities regulatory authority or under the relevant laws of any state or other jurisdiction of the United States, and may not be offered, sold, taken up, exercised, resold, pledged, renounced, transferred or delivered, directly or indirectly, into or within the United States, except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with any applicable securities laws of any state or other jurisdiction of the United States. There has been and will be no public offering of the New Shares in the United States.

 

The release, publication or distribution of this announcement in jurisdictions outside the United Kingdom, the Republic of Ireland and South Africa may be restricted by law and, therefore, persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply which such restrictions may constitute a violation of the securities law of any such jurisdiction.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAPESEDEAFFA
Date   Source Headline
22nd Aug 20232:45 pmRNSHolding(s) in Company
21st Aug 20233:30 pmRNSHolding(s) in Company
18th Aug 20233:00 pmRNSHolding(s) in Company
14th Aug 20239:30 amRNSDividend Currency Conversion Announcement
10th Aug 20233:00 pmRNSHolding(s) in Company
27th Jul 20234:30 pmRNSInterim Dividend Record Date Correction
27th Jul 20237:01 amRNSDividend Declaration
27th Jul 20237:00 amRNSHalf-year Report
5th Jul 20237:00 amRNSNotice of Results & IASB Accounting Interpretation
22nd Jun 202311:30 amRNSHolding(s) in Company
22nd Jun 20237:00 amRNSHolding(s) in Company
14th Jun 20239:30 amRNSHolding(s) in Company
12th Jun 20231:15 pmRNSHolding(s) in Company
31st May 20239:00 amRNSBlock listing Interim Review
30th May 202311:30 amRNSHolding(s) in Company
17th May 20239:00 amRNSDirector/PDMR Shareholding
4th May 20234:15 pmRNSResult of AGM
28th Apr 20234:15 pmRNSDirector/PDMR Shareholding
26th Apr 20233:30 pmRNSHolding(s) in Company
25th Apr 20237:00 amRNSPre AGM trading update
17th Apr 20234:00 pmRNSHolding(s) in Company
14th Apr 20239:00 amRNSHolding(s) in Company
13th Apr 20233:00 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:00 amRNSAnnual Report and Notice of Annual General Meeting
3rd Apr 20237:00 amRNSDisposal
21st Mar 20235:15 pmRNSDirector/PDMR Shareholding
10th Mar 202311:45 amRNSHolding(s) in Company
9th Mar 20237:00 amRNSFinal Results
6th Mar 20233:30 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSIASB Accounting Interpretation
16th Jan 20233:00 pmRNSNotice of Results and Registered Office Change
30th Nov 202210:00 amRNSBlock listing Interim Review
23rd Nov 202212:45 pmRNSShare capital reduction confirmation
22nd Nov 202212:30 pmRNSHolding(s) in Company
10th Nov 20228:00 amRNSDirector/PDMR Shareholding
8th Nov 20223:45 pmRNSDirector/PDMR Shareholding
8th Nov 20227:00 amRNSQ3 trading, operational and rent collection update
3rd Nov 20227:43 amRNSTotal Voting Rights
3rd Nov 20227:00 amRNS2023 EUR500,000,000 1.750 per cent Bond Redemption
1st Nov 20229:45 amRNSInterim Dividend and Enhanced Scrip Alternative
25th Oct 20222:30 pmRNSResult of General Meeting
19th Oct 202210:45 amRNSBoard Committee Appointment
12th Oct 20227:00 amRNSDirectorate Change
6th Oct 20224:00 pmRNSHolding(s) in Company
6th Oct 202210:00 amRNSCash Fractions for the Enhanced Scrip Dividend
30th Sep 20224:30 pmRNSHolding(s) in Company
28th Sep 202210:00 amRNSCircular, Notice of Meeting and Form of Proxy
27th Sep 20229:30 amRNSCurrency Conversion & Scrip Reference Share Price
14th Sep 20224:00 pmRNSInterim 2022 Dividend Expected Timetable of Events
18th Aug 202212:15 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.